Haroutunian V - Search Results

1

Altered succinylation of mitochondrial proteins, APP and tau in Alzheimer's disease.

Yang Y, Tapias V, Acosta D, Xu H, Chen H, Bhawal R, Anderson ET, Ivanova E, Lin H, Sagdullaev BT, Chen J, Klein WL, Viola KL, Gandy S, Haroutunian V, Beal MF, Eliezer D, Zhang S, Gibson GE. Yang Y, et al. Among authors: haroutunian v. Nat Commun. 2022 Jan 10;13(1):159. doi: 10.1038/s41467-021-27572-2. Nat Commun. 2022. PMID: 35013160 Free PMC article.

2

Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.

Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP. Gibson GE, et al. Among authors: haroutunian v. Ann Neurol. 2000 Sep;48(3):297-303. Ann Neurol. 2000. PMID: 10976635

3

Correlation of the clinical severity of Alzheimer's disease with an aberration in mitochondrial DNA (mtDNA).

Brown AM, Sheu RK, Mohs R, Haroutunian V, Blass JP. Brown AM, et al. Among authors: haroutunian v. J Mol Neurosci. 2001 Feb;16(1):41-8. doi: 10.1385/JMN:16:1:41. J Mol Neurosci. 2001. PMID: 11345519

4

Altered Abeta formation and long-term potentiation in a calsenilin knock-out.

Lilliehook C, Bozdagi O, Yao J, Gomez-Ramirez M, Zaidi NF, Wasco W, Gandy S, Santucci AC, Haroutunian V, Huntley GW, Buxbaum JD. Lilliehook C, et al. Among authors: haroutunian v. J Neurosci. 2003 Oct 8;23(27):9097-106. doi: 10.1523/JNEUROSCI.23-27-09097.2003. J Neurosci. 2003. PMID: 14534243 Free PMC article.

5

Mitochondrial enzymes in schizophrenia.

Bubber P, Tang J, Haroutunian V, Xu H, Davis KL, Blass JP, Gibson GE. Bubber P, et al. Among authors: haroutunian v. J Mol Neurosci. 2004;24(2):315-21. doi: 10.1385/JMN:24:2:315. J Mol Neurosci. 2004. PMID: 15456945

6

Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.

Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE. Bubber P, et al. Among authors: haroutunian v. Ann Neurol. 2005 May;57(5):695-703. doi: 10.1002/ana.20474. Ann Neurol. 2005. PMID: 15852400

7

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology.

Beeri MS, Schmeidler J, Silverman JM, Gandy S, Wysocki M, Hannigan CM, Purohit DP, Lesser G, Grossman HT, Haroutunian V. Beeri MS, et al. Among authors: haroutunian v. Neurology. 2008 Sep 2;71(10):750-7. doi: 10.1212/01.wnl.0000324925.95210.6d. Neurology. 2008. PMID: 18765651 Free PMC article.

8

nELAV proteins alteration in Alzheimer's disease brain: a novel putative target for amyloid-beta reverberating on AbetaPP processing.

Amadio M, Pascale A, Wang J, Ho L, Quattrone A, Gandy S, Haroutunian V, Racchi M, Pasinetti GM. Amadio M, et al. Among authors: haroutunian v. J Alzheimers Dis. 2009;16(2):409-19. doi: 10.3233/JAD-2009-0967. J Alzheimers Dis. 2009. PMID: 19221430 Free PMC article.

9

SCFFbx2-E3-ligase-mediated degradation of BACE1 attenuates Alzheimer's disease amyloidosis and improves synaptic function.

Gong B, Chen F, Pan Y, Arrieta-Cruz I, Yoshida Y, Haroutunian V, Pasinetti GM. Gong B, et al. Among authors: haroutunian v. Aging Cell. 2010 Dec;9(6):1018-31. doi: 10.1111/j.1474-9726.2010.00632.x. Epub 2010 Oct 29. Aging Cell. 2010. PMID: 20854419 Free PMC article.

10

CR1 and the "vanishing amyloid" hypothesis of Alzheimer's disease.

Gandy S, Haroutunian V, DeKosky ST, Sano M, Schadt EE. Gandy S, et al. Among authors: haroutunian v. Biol Psychiatry. 2013 Mar 1;73(5):393-5. doi: 10.1016/j.biopsych.2013.01.013. Biol Psychiatry. 2013. PMID: 23399469 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters